Loading...
AI-driven drug discovery: A boon against COVID-19?
The COVID-19 is an issue of international concern and threat to public health and there is an urgent need of drug/vaccine design. There is no vaccine or specific drug yet made as of July 23, 2020, for the coronavirus disease (COVID-19). Thus, the patients currently can only be treated symptomaticall...
Saved in:
| Published in: | AI Open |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
The Authors. Published by Elsevier B.V. on behalf of KeAi Communications Co., Ltd.
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7396325/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.aiopen.2020.07.001 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|